Explore our perspective on key HealthTech topics, and discover the approach and strategy that guide our work.

featured CONTENT

01

The Philosopher's Diagnosis: What Aristotle Would Prescribe for AI in Medicine

Explore how Aristotle’s ideas still illuminate AI in medicine, and why the real question is not what AI can do, but what healthcare is for.

Prof. Shafi Ahmed

Innovation Didn't Wait: The State of Healthcare AI Regulation in 2026

Explore where global healthcare AI regulation actually stands in 2026 - and why the technology is still outrunning the rulebook.

Prof. Shafi Ahmed

More Convinced. More Cautious: What the Evidence on Medical AI Now Tells Us

Discover how frontier LLMs already deliver real clinical value when deployed as carefully supervised tools that augment, not replace, clinicians.

Prof. Shafi Ahmed

December 18, 2025

Prof. Shafi Ahmed, Renowned Health Futurist and Nobel Prize Nominee, Joins PurposeTech’s Second Fund as a Senior Partner

PurposeTech has announced that Professor Shafi Ahmed is joining the firm as a Senior Partner, ahead of the launch of its second HealthTech-focused fund in January 2026.

OTHER ARTICLES

02

December 16, 2025

Why Early-Stage HealthTech Needs a Different Investment Playbook

Learn how niche-focused, clinically grounded capital can drive paced, profitable innovation.

December 4, 2025

Podcast: Rethinking Early-stage HealthTech

In this podcast, Fred Fous and Prof. Shafi Ahmed, Partners at PT Capital, unpack the real lessons from building the first fund and how those experiences shaped their view of what actually works in early-stage HealthTech.

No items found.

December 16, 2025

Why Early-Stage HealthTech Needs a Different Investment Playbook

Learn how niche-focused, clinically grounded capital can drive paced, profitable innovation.

December 4, 2025

Podcast: Rethinking Early-stage HealthTech

In this podcast, Fred Fous and Prof. Shafi Ahmed, Partners at PT Capital, unpack the real lessons from building the first fund and how those experiences shaped their view of what actually works in early-stage HealthTech.